Report: German Medical Cannabis Prescriptions Increased 1,000% In 9 Months
According to a recent report by the Bloomwell Group, prescriptions for medical cannabis in Germany increased by roughly 1,000% between March 2024 and December 2024. The report also found that prices for medical cannabis products are decreasing in Europe’s largest medical cannabis market.
“Despite the rapid increase in cannabis patients, companies, doctors and pharmacies have ensured a secure supply,” explained Niklas Kouparanis, co-founder and CEO of Bloomwell, according to reporting by apotheke-adhoc.
“We are at the very beginning of a new era,” emphasized Kouparanis. “It is now the task of the next federal government to shape the regulatory framework in such a way that jobs continue to be created, investors are given security and innovation is promoted so that patients continue to benefit from cost-effective access to therapy.”
Germany adopted the first provisions of its new adult-use cannabis legalization law on April 1st, 2024. The provisions involved permitting adults to cultivate, possess, and consume personal amounts of cannabis. Additionally, cannabis was removed from Germany’s Narcotics List. The latter provision has provided a major boost to Germany’s medical cannabis industry.
Another component of Germany’s new legalization model involves permitting cultivation associations. The application process for cultivation associations started on July 1st, 2024, and to date, 83 cultivation applications have been approved, with hundreds more working their way through the process.
Germany was already home to the largest legal medical cannabis industry in Europe before the enactment of adult-use legalization, and changes in medical cannabis policies and regulations in 2024 have resulted in a domestic medical cannabis boom, as demonstrated by the data in Bloomwell’s recent report.
Legal medical cannabis imports continue to rise in Germany as well. During the first three full months following Germany’s enactment of the CanG adult-use legalization law (Q3), legal medical cannabis imports increased by over 70% compared to the previous period.
Alex Rogers, founder and CEO of the International Cannabis Business Conference, recently visited Helios’ Munich pharmacy location to see their world-class operations firsthand, which can be viewed in the video embedded below. The video provides a great glimpse into Germany’s emerging legal medical cannabis industry:
